ORIGINAL ARTICLE
THE PATTERN OF INFECTIVE ENDOCARDITIS
IN A TERTIARY CARE
HOSPITAL IN OMAN: A TEN-YEAR
PROSPECTIVE STUDY
K.J.Suleiman, FRCPI, P.Prashanth
MD
Department of Cardiology, Royal Hospital, Muscat,
Oman.
Background:
The previous
50 years have seen major changes in the epidemiology
of infective endocarditis (IE).
Aim: To evaluate local risk factors, clinical
manifestations, microbiology, echocardiographic
features, morbidity and mortality in patients
with definite IE.
Design: Prospective observational study.
Method: Over a ten year period, patients
referred with probable IE were evaluated. All
had received a standardized diagnostic evaluation
as per department protocol. Epidemiological data
were documented; underlying risk factors for IE
were noted. Initial evaluation and follow-up included
documentation of vascular or immunological phenomena,
morbidity and mortality.
Results: Of 90 patients referred with probable
IE, 50 had definite IE. The mean age was 36 yrs
with a male predominance (1.2:1). Rheumatic heart
disease was present in 20 (40%). Eight had mitral
valve prolapse and congenital heart disease respectively,
and three had prosthetic valves. All had denied
the use of intravenous recreational drugs and
11 had normal valve endocarditis. Cardiac murmur
(98%) and fever (96%) were commonly observed.
Six patients had renal involvement and ten patients
had embolic episodes. Vegetations were seen in
80% of patients. 70% were managed medically, 10%
surgically, and mortality was 20%. An etiological
diagnosis was made in 29 patients with viridans
streptococci the most common isolate.
Conclusions: Infective endocarditis in
Oman is a disease of younger adults, with a male
predominance. Rheumatic heart disease is the major
predisposing factor. Degenerative heart disease
and intravenous drug abuse are not important risk
factors. Local mortality rates are similar to
published rates but the proportion of “culture-negative”
IE was higher. Large vegetations were important
prognostically.
Heart Views. 2003;4(3):89-93 © 2003 Gulf
Heart Association
Key words:
Infective endocarditis
Rheumatic heart disease
vegetations
The later part of the
20th century has seen predominant changes in the
epidemiology, bacteriology and clinical presentation
of infective endocarditis and major advances in
the diagnosis and management of this disease (1,2).
The changes observed in the patient profile of
the disease in the developed world, as well as
decline in “culture-negative” endocarditis have
been highlighted extensively. IE was previously
described as a disease of younger adults with
underlying rheumatic heart disease (RHD), but
now its distribution has shifted as a disease
of older patients with a different spectrum of
risk factors and clinical sequelae (1). Changes
in patient profile have largely been attributed
to a declining incidence of rheumatic fever, a
greater prevalence of degenerative heart disease
and accompanying increased longevity, intravenous
drug abuse, the increasing number of patients
with prosthetic valves, and longer survival of
patients with congenital heart disease(1).
Despite
the high prevalence of rheumatic heart disease
in Oman, few data have been published on the epidemiological
relationship of infective endocarditis and rheumatic
heart disease or any other potential risk factors
seen in Oman. In this study, patients with infective
endocarditis (IE) were evaluated with regard to
epidemiological characteristics, identifiable
risk factors and their clinical presentation,
microbiology, morbidity, and mortality.
All patients referred
to the Department of Cardiology , Royal Hospital
with the presumptive diagnosis of IE were studied
prospectively over a period of ten years between
1992 to 2002. IE was diagnosed according to the
Duke’s criteria (3) from 1994.
Royal Hospital
is a 650-bed teaching hospital in Muscat,Oman.
All subjects were clinically evaluated
on the day of referral, and daily while in hospital
thereafter. Baseline characteristics were collected
and a detailed history was taken. Specific attention
was paid to potential risk factors, which included
a history of previous rheumatic fever or valvular
heart disease, previous infective endocarditis,
congenital heart disease, mitral valve prolapse,
cardiac surgery (valve replacement or repair),
intravenous drug use, degenerative heart disease,
indwelling intravenous catheters, medical or surgical
procedure at risk of bacteremia within one month
prior to hospitalization or other potential risk
factors. During the physical examination, the
presence or absence of any vascular or immunological
phenomena (as defined by the Duke criteria) were
actively sought and documented.
During the evaluation, three blood cultures for
aerobic/anaerobic organisms were taken from three
different sites, approximately half an hour apart.
Any exposure to oral or intravenous antibiotics
during the two days prior to the attainment of
blood cultures was documented. All patients were
examined by transthoracic echocardiography using
Hewlett Packard S 1500. Vegetations were defined
according to Duke criteria. Transesophageal echocardiography
(TEE) was performed in 30 patients. Further investigations
included an ECG, full blood count, ESR, routine
biochemistry, Serology [C-reactive protein (CRP),
Rheumatoid factor, Antinuclear factor], and urinalysis.
The microbiology department of Royal Hospital
performed all microbiological investigations.
Organisms were identified by standard laboratory
practices. Finally, the Duke criteria (as published
in 1994) were strictly applied to classify all
patients as either “definite”, “possible” or “rejected”
infective endocarditis.
All patients were managed according
to published guidelines(4,5,6). Cultures and antimicrobial
susceptibility testing guided the choice of antibiotics,
whereas empirical therapy was given to culture-negative
cases. Patients who presented with subacute form
of IE of native valves generally received 4-6
weeks IV penicillin G (20 MU/day ) or ampicillin
IV (12Gm/day) and gentamicin (1mg/kg q8h IV x
2 weeks ), whereas cloxacillin IV (12Gm/day) was
added to the treatment in those presenting with
more acute disease. The B-lactam antibiotics were
substituted by vancomycin if methicillin-resistant
staphylococci were suspected or if penicillin
allergy.
Prosthetic valve endocarditis was treated with
a combination of intravenous vancomycin and oral
rifampicin for 6 weeks in combination with intravenous
gentamicin for the first 2 weeks.
In culture-negative endocarditis, antibiotics
were given for 6 weeks. All patients were seen
daily while in hospital and at 3 and 6 months
after discharge.
Collected data were stored in a
Microsoft Access database. The baseline characteristics
of all patients were evaluated to identify known
risk factors and to calculate the mean age and
gender distribution. Morbidity parameters were
documented to attain their relative frequency
in definite IE. Patients lost to follow-up were
excluded from the analysis of 6 month crude mortality
rate.
Ninety patients with suspected IE were
evaluated during the study period. Of these, 50
were ultimately diagnosed as having definite IE.
Mean duration of hospital stay was 40+/-10 days.
Baseline characteristics and clinical manifestations
are summarized in Table 1 and 2 respectively.
Table 1 .
Baseline Characteristics (50 Patients)
Table 2. Clinical Manifestations
(50 Patients)

An etiological diagnosis was reached in 29 of
50 patients. The positive blood cultures yielded
the following organisms: viridans streptococci
(n=16, 32%), staphylococci (n=10, 20%) and gram
negative bacilli (n=3, 6 %). Of the remaining
21 patients with culture negative IE, all had
received oral or intravenous antibiotics during
48hrs preceding collection of blood cultures,
whereas only 4 of 29 patients with positive blood
cultures had received antimicrobial agents.
Figure
1 represents etiological diagnosis in 29 patients.
Fig.1. Etiological
diagnosis
Echocardiography (TTE +/-TEE) was
done in all 50 patients, vegetations were found
in 40(80%) patients. Locations of vegetations
were: native aortic valve 16 patients, native
mitral valve 13 patients, combined native aortic
and mitral valve 8 patients and prosthetic valves
3 patients. 21 of these patients had vegetation
of > 10 mm. After evaluating various variables,
70% of all hospital deaths, 75% of those with
embolic manifestations and 100% of those requiring
early surgery were among patients with large vegetation
size > 10mm(7,8).
Thirty-five of 50 patients (70%)
were managed medically and improved on antibiotics,
5 patients (10%) needed valve replacement.
The
six-month crude mortality rate of patients with
definite IE was 20% including 2 patients operated
and expired. Among three patients with prosthetic
valve endocarditis one needed redo valve replacement.
Figure 2 represents prognosis in 50 patients.

Fig. 2. Prognosis
Patients with definite IE had a
mean age of 36 years (SD 11 years ). 40% of patients
with native valve endocarditis had rheumatic heart
disease, which is comparable to other studies
with similar incidence (7). Previous studies in
the developed world have reported more than half
of all new cases of infective endocarditis occur
in patients older than 50 years with RHD implicated
in < 25% (1,2,11). In our series, the incidence
of RHD was much higher. In the USA, it has been
reported that mitral valve prolapse is the most
common underlying abnormality in patients with
IE. (1) Intravenous drug abuse and degenerative
heart disease are two commonly seen risk factors
for IE in the US, which was not seen in our series.
A number of large studies (5) reported that IE
occurs more commonly in men, with a male:female
ratio of 1.7:1 (range 1.0 -3.0: 1) and the ratio
of 1.2 :1 in our study confirms this discrepancy
in gender-associated risk.
50 of the 90 patients enrolled satisfied
the Duke criteria for definite IE, but an etiological
diagnosis could be established in 58% of these
cases. In the USA, culture negative endocarditis
constitutes only 2.5 - 30% of all IE diagnosed,
while in the Netherlands, this figure is even
as low as 1.1% (1). We found that all 21 patients
with culture negative IE had been exposed to antibiotics
within 48 hrs prior to blood culture sampling.
Contrary to the trends observed in industrialized
countries (Group D streptococci / staphylococci
) (1,2,9), viridans streptococci was still the
most common isolate in our study, probably due
to poor dental health. Staphylococcus epidermidis
was isolated in patients with prosthetic valve
endocarditis.
According to published data, 10%
or more of patients with definite IE do not have
an audible cardiac murmur (5), whereas 98% of
patients with definite IE in this study presented
with a cardiac murmur on auscultation. The reasons
for this discrepancy may reflect the differences
in epidemiology and risk factors profile of our
patients.
We found immunological phenomena (Table 2) to
be common and in keeping with the subacute presentation
of IE seen in the majority of patients. Our clinical
data are remarkably similar to those previously
published (1,5).
The all cause 6-month mortality rate of 20% found
in our patients with definite IE was similar to
published rates (range 16-27%) (1,2). Among the
five operated patients three survived, as they
presented early and needed intervention (10).
The pattern of Infective Endocarditis
in the Royal Hospital in Oman has distinct epidemiological
features. It is still a disease of younger adults
with a male predominance. Chronic rheumatic heart
disease is the major predisposing factor (in contrast
to trends described in the developed world), whereas
degenerative heart disease and intravenous drug
abuse are not. The high incidence of Culture negative
endocarditis is probably attributed to the use
of antibiotics prior to referral to Royal Hospital.
Among the various parameters studied, only vegetation
size =/> 10 mm was associated with increased mortality,
embolic manifestations and need for early surgery.
¨
1.
Mylonakis E , Calderwood SB.
Infective Endocarditis in Adults. N Eng J Med
2001;234:
1318 -28.
2.
Hoen B, Alla F, Selton-Suty C,
et al. Changing profile of infective endocarditis:
results of a 1-year survey in France. JAMA 2002;
288:75-81.
3.
Durack DT , Lukes AS, Bright
DK. New criteria for diagnosis of infective endocarditis:
utilization of specific echocardiographic findings.
Am J Med 1994;96:200.
4.
Wilson WR, Kachmer AW, Dajani
AS, et al. Antibiotic treatment of adults with
infective endocarditis due to streptococci, enterococci
, staphylococci and HACEK microorganisms.
JAMA
1995; 274 :1706-13.
5.
Karchmer AW. Infective Endocarditis.
In: Braunwald E, ed. Heart Disease: A Textbook
of Cardiovascular Medicine, 5th edn. WB Saunders,1997:
1769-74.
6.
Thomas H. Lee. Guidelines for
prevention, evaluation and management of infective
endocarditis. In: Braunwald E, ed. Heart disease:
A textbook of Cardiovascular medicine 6th edn.
WB Saunders, 200;1748-50.
7.
Keogelenberg CFN, Doubell AF,
et al. Infective endocarditis in the Western Cape
Province of South Africa : a three-year prospective
study. Q J Med 2003; 96:217-225.
8.
Bayer AS, Bolger AF , Taubert
KA ,et al : Diagnosis and management of infective
endocarditis and itís complications. Circulation
1998; 98; 2936-48.
9.
Roder BL, Wandall DA, Frimodt-Moller
N, et al. Clinical features of Staphylococcus
aureus endocarditis: a 10-year experience in Denmark.
Arch Intern Med. 1999; 159:462.
10.
Olaison L, Hogevik H, Myken
P, Oden A. Early surgery in infective endocarditis.
QJM. 1996; 89:267-278.
11.
Sexton DJ, Bashore TM. Infective
endocarditis. In : Eric.J.Topol, Textbook of cardiovascular
medicine, 2nd ed. LWW, 2002; 569-93.
ENGROSSED IN HIS WORLD
Kneeling Bull Holding Vessel
c. 2900 B.C., Proto-Elamite period,
silver
Still, serene, self-contained and
mysterious, the bull seems to know a lot . . .
what secrets does he hold . . . what does he represent?
A myth, in which animals acted as humans? An animal
god? Or is the bull merely an elaborate handle
for the long vase?
1Senior Consultant, Department of Cardiology, Royal Hospital, Muscat, Oman,
2Registrar,
Department of Cardiology, Royal Hospital, Muscat, Oman
Correspondence to Dr.P.Prashanth,Department
of Cardiology, Royal HospitalPB 133
Muscat-111,Oman.
E-mail- apurvp@omantel.net.om
|
|